Results 91 to 100 of about 6,970,743 (315)

Financial deregulation in developing countries. [PDF]

open access: yes
Country; Developing countries;
De Grauwe, Paul
core  

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Telemedicine in Developing Countries

open access: yesVoices in Bioethics, 2014
Voices in Bioethics, Archives (2014-2015)
openaire   +2 more sources

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane   +19 more
wiley   +1 more source

Transit transport issues in landlocked and transit developing countries

open access: yes, 2003
Landlocked developing countries are confronted with a range of unique constraints that inhibit full participation in the globalization process. At the same time, economic development and emerging opportunities for interregional trade are stimulating ...
UN.ESCAP
core   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Application of models in predicting sputum conversion after two months of intensive phase of anti-tuberculosis medication in Taraba State

open access: yesInternational Journal of Infectious Diseases
Introduction: Tuberculosis is a preventable and curable disease. However, it is still a leading cause of morbidity and mortality from an infectious disease, with over 10 million yearly infections.
D. N Kevin   +5 more
doaj   +1 more source

Telecommunications Technologies: Deployment in Developing Countries [PDF]

open access: yes
This paper examines some policies pursued in developing countries for the provision of telecommunications services in rural areas. These policies significantly differ from those typically implemented in developed countries in their fundamental objectives,
Recuero Virto, Laura, Gasmi, Farid
core  

A conceptual framework for e-learning in developing countries: A critical review of research challenges

open access: yes, 2009
This paper presents a critical review of research on challenges for e-learning with a particular focus on developing countries. A comprehensive literature review including 60 papers on e-learning challenges was undertaken for the purpose of understanding
Annika Andersson   +3 more
core   +1 more source

Building Tax Capacity in Developing Countries [PDF]

open access: yes, 2015
The agenda for the Third International Conference on Financing for Development suggests there will be less focus on aid, and more on how developing countries can generate their own financial resources for development.
McCluskey, Rhiannon   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy